A new international study has found that medications used to treat diabetes and obesity may also help improve mental health.
The research focused on a group of drugs called GLP-1 receptor agonists, including semaglutide, which is commonly prescribed for weight loss and blood sugar control.
Many people living with obesity or diabetes also struggle with mental health issues. These conditions often go together.
Physical health problems can increase stress and reduce quality of life, while mental health issues can make it harder to manage weight and diet. Because of this close connection, scientists have been interested in whether treatments for the body could also affect the mind.
In this study, researchers from several universities examined data from Swedish health records. They followed nearly 100,000 people over more than a decade. Around 20,000 of these individuals had used GLP-1 medications at some point.
The findings were clear and surprising. During periods when people were taking semaglutide, they were much less likely to need hospital care for mental health problems. They also had fewer days off work due to mental illness.
The study found that depression was reduced by 44 percent and anxiety by 38 percent among people using the medication. These improvements suggest that the drugs may have a strong positive effect on emotional well-being.
The researchers also looked at substance use. They found that problems related to alcohol and other substances were lower among people taking GLP-1 drugs. There was also a reduced risk of suicidal behavior, which is an important finding for public health.
There are several possible explanations for these results. One is that improving physical health can naturally improve mental health. Losing weight, controlling blood sugar, and feeling healthier may boost mood and confidence. Another explanation is that these drugs may act directly on the brain, especially on systems related to reward and pleasure.
The study was published in The Lancet Psychiatry and is one of the largest of its kind. Earlier studies have shown mixed results, but this research provides stronger evidence because of its size and detailed data.
Even so, the researchers caution that the study does not prove a direct cause. Because it is based on health records, other factors may have influenced the results. For example, people taking these medications may also be more engaged with healthcare services or lifestyle changes.
From a critical perspective, the study is important because it highlights a possible new benefit of widely used drugs. The large sample size and long follow-up period strengthen the findings. However, more controlled studies are needed to confirm the results and understand how the drugs affect the brain.
In conclusion, GLP-1 medications may not only help with weight and blood sugar but also support mental health. This opens new possibilities for treating people with both physical and mental health challenges.
If you care about depression, please read studies that vegetarian diet may increase your depression risk, and Vitamin D could help reduce depression symptoms.
For more information about health, please see recent studies that ultra-processed foods may make you feel depressed, and these antioxidants could help reduce the risk of dementia.
Source: University of Eastern Finland.
